Blueberry Compound Helps Muscle Cells Burn Stored Fat by Protecting a Key Protein
Key Takeaways:
- Researchers in Japan have identified pterostilbene, a polyphenol found in blueberries, grapes and other berries, as a dietary compound that reduces abnormal fat accumulation inside cultured skeletal muscle cells.
- The compound works through an unexpected route: rather than switching on the fat-burning receptor PPARδ directly, it protects the PPARδ protein from being broken down, leaving more of it available inside the cell.
- The findings are currently limited to molecular experiments in cultured mouse muscle cells, so they do not yet show that pterostilbene can prevent or treat metabolic conditions in animals or in people.
Why fat inside muscle matters
Excess fat stored inside skeletal muscle has become an important metabolic health concern. This type of fat buildup can be encouraged by high-fat diets, physical inactivity and ageing – three factors that are widespread in contemporary populations and that often occur together.
Crucially, fat held within muscle behaves differently from fat stored under the skin. Lipid droplets that accumulate inside muscle cells can interfere with normal muscle function and make it harder for the body to use glucose and fatty acids efficiently. Over time, this reduced metabolic flexibility can contribute to insulin resistance.
That connection is what makes fat inside muscle, known clinically as myosteatosis, more than a question of body composition. Finding ways to limit excess fat inside skeletal muscle could be important for supporting healthy ageing and reducing the risk of lifestyle-related disease.
One pathway plays a particularly important role in this process: peroxisome proliferator-activated receptor δ, usually shortened to PPARδ. When PPARδ signalling is active, it promotes fatty acid oxidation and helps limit the accumulation of lipids inside cells. In other words, an active PPARδ pathway pushes muscle cells towards using fat as fuel rather than storing it.
That has made PPARδ an attractive target. Researchers have become increasingly interested in food-derived bioactive compounds that may influence this pathway, but exactly how these substances affect PPARδ has remained unclear – a gap that limits how confidently any such compound can be developed into a practical intervention.
A berry compound targets muscle fat metabolism
A research team in Japan led by Associate Professor Takakazu Mitani of Shinshu University has now identified pterostilbene as a natural dietary compound that can stabilise PPARδ and influence fat metabolism inside muscle cells.
Pterostilbene is a naturally occurring polyphenol found in blueberries, grapes and other berries. Previous research has linked the compound to beneficial metabolic effects in the liver and in adipose tissue, but scientists knew much less about how it might affect skeletal muscle. The new findings were published in Volume 83 of the journal Food Bioscience on 1 September 2026.
The team’s starting point was a therapeutic gap rather than a specific molecule.
“We currently lack approved treatments specifically targeting myosteatosis,” says Dr Mitani. “This critical gap led our team to screen food-derived compounds for natural, dietary interventions. During the screening, we identified pterostilbene and focused our investigation on uncovering its precise mechanism of action.”
Screening food compounds for fat reduction
To investigate potential natural approaches, the researchers tested a collection of food-derived phytochemicals using cultured C2C12 mouse skeletal muscle cells – a well-established laboratory model for studying how muscle cells develop and handle fuel.
The screen was designed around two requirements rather than one. The researchers examined whether the compounds could reduce abnormal fat accumulation inside the cells, and whether they could do so without interfering with normal muscle development. A compound that stripped fat from muscle cells at the cost of impairing the muscle itself would be of little practical value.
Among the compounds tested, pterostilbene produced the strongest reduction in intracellular lipid accumulation. Importantly, the treated muscle cells continued to grow and differentiate normally.
The next question was how the reduction was being achieved. Broadly, a compound could lower fat inside a cell either by blocking fat from getting in or by increasing the rate at which stored fat is broken down. Further experiments showed that pterostilbene did not work by preventing fatty acids from entering the muscle cells. Instead, the researchers detected increased release of glycerol outside the cells, which is an important sign that stored fat is being broken down.
The treated cells also showed greater expression of genes involved in fatty acid oxidation – the process by which fatty acids are actually consumed for energy. Together, these results suggest that pterostilbene encourages muscle cells to break down stored lipids and process them for energy, rather than simply keeping fat out.
Protecting a key fat metabolism protein
The researchers then investigated the molecular mechanism behind these effects and found that pterostilbene significantly increased PPARδ signalling.
The way it accomplished this was unexpected. Many experimental compounds designed to stimulate PPARδ work by binding directly to the receptor and activating it, in the manner of a conventional drug acting on its target. Pterostilbene appeared to operate differently.
Instead of directly activating PPARδ, the compound increased the amount of PPARδ protein present inside the cells. It did this by preventing the protein from being broken down through the ubiquitin-proteasome pathway, the cell’s main route for tagging proteins for disposal and recycling them.
By slowing the degradation of PPARδ, pterostilbene allowed more of the protein to remain available inside the cell. This stabilisation increased PPARδ transcriptional activity and boosted the activity of genes involved in lipid metabolism.
Why the mechanism matters
Identifying the mechanism does more than explain a single result. It sets out a route that other researchers can follow, and Dr Mitani frames the work in exactly those terms.
“Our findings establish a scientific framework for developing functional foods and nutritional supplements that target muscle fat metabolism. However, beyond the potential of pterostilbene itself, this work provides an experimental framework for identifying other natural compounds that can stabilize the PPARδ protein,” mentioned Dr Mitani.
For healthcare professionals, questions about the role of specific dietary components in metabolic health arrive regularly in consultations, often well ahead of the evidence needed to answer them. Interpreting that evidence and translating it into practical dietary conversations is covered in CCH’s CPD short course Nutrition & Weight Management Essentials.
Potential implications for metabolic health
With metabolic diseases becoming increasingly common worldwide, the findings provide a starting point for studying dietary approaches that could eventually contribute to strategies for obesity, type 2 diabetes and age-related metabolic decline.
However, the results are still limited to molecular experiments in cultured mouse muscle cells. They do not yet demonstrate that pterostilbene can prevent or treat these conditions in animals or in people.
Even so, the researchers say the compound could serve as a promising candidate bio-ingredient for the food and healthcare industries as they explore new functional products aimed at muscle fat metabolism.
What still needs to be established
Additional in vivo research will be necessary to determine whether the effects translate beyond cultured cells. Future studies will also need to evaluate effectiveness, safety, and how selectively pterostilbene acts on its intended biological targets before the findings can be developed into practical nutritional or pharmaceutical applications.
Until that work is done, the most accurate description of pterostilbene is a well-characterised laboratory finding with a clearly mapped mechanism – valuable as a foundation for further research, but not yet a basis for dietary or clinical recommendations.
CCH insight
Conversations about diet, body composition and metabolic health are a routine part of practice, and people living with obesity or type 2 diabetes often ask about specific foods and supplements long before the research is settled. The Nutrition & Weight Management Essentials CPD short course from The College of Contemporary Health equips healthcare professionals to appraise nutritional evidence and apply it in everyday practice.
